Vaccine and Treatment Evaluation Units

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $7,831,958
  • Funder

    National Institutes of Health (NIH)
  • Principle Investigator

    Pending
  • Research Location

    United States of America, Americas
  • Lead Research Institution

    EMORY UNIVERSITY
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 3 clinical trial

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase III

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Summary/AbstractThe Emory VTEU has proven essential in the fight against the pandemic. This supplement will allow for furtherinvestigations into Treatments trials (20-0006) and Vaccines trials (20-0003 and Moderna Phase III) againstCOVID-19.1